These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36064725)

  • 1. Phenotypic expression of swallowing function in Niemann-Pick disease type C1.
    Solomon BI; Muñoz AM; Sinaii N; Farhat NM; Smith AC; Bianconi S; Dang Do A; Backman MC; Machielse L; Porter FD
    Orphanet J Rare Dis; 2022 Sep; 17(1):342. PubMed ID: 36064725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swallowing characterization of adult-onset Niemann-Pick, type C1 patients.
    Solomon BI; Muñoz AM; Sinaii N; Mohamed H; Farhat NM; Alexander D; Do AD; Porter FD
    Orphanet J Rare Dis; 2024 Jun; 19(1):231. PubMed ID: 38863022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
    Solomon BI; Smith AC; Sinaii N; Farhat N; King MC; Machielse L; Porter FD
    JAMA Neurol; 2020 Dec; 77(12):1564-1568. PubMed ID: 32897301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1.
    Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Navid F; Wassif CA; Cawley NX; Porter FD
    Mol Genet Metab; 2021 Dec; 134(4):330-336. PubMed ID: 34802899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1.
    Cawley NX; Giddens S; Farhat NM; Luke RA; Scott KEJ; Mohamed HO; Dang Do A; Berry-Kravis E; Cologna SM; Liu F; Porter FD
    Mol Genet Metab; 2023 Nov; 140(3):107656. PubMed ID: 37517328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1.
    Agrawal N; Farhat NY; Sinaii N; Do AD; Xiao C; Berry-Kravis E; Bianconi S; Masvekar R; Bielekova B; Solomon B; Porter FD
    Genet Med; 2023 Mar; 25(3):100349. PubMed ID: 36470574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.
    Ory DS; Ottinger EA; Farhat NY; King KA; Jiang X; Weissfeld L; Berry-Kravis E; Davidson CD; Bianconi S; Keener LA; Rao R; Soldatos A; Sidhu R; Walters KA; Xu X; Thurm A; Solomon B; Pavan WJ; Machielse BN; Kao M; Silber SA; McKew JC; Brewer CC; Vite CH; Walkley SU; Austin CP; Porter FD
    Lancet; 2017 Oct; 390(10104):1758-1768. PubMed ID: 28803710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability.
    Brogden G; Shammas H; Walters F; Maalouf K; Das AM; Naim HY; Rizk S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterol O-Acyltransferase 1 (
    Farhat NY; Alexander D; McKee K; Iben J; Rodriguez-Gil JL; Wassif CA; Cawley NX; Balch WE; Porter FD
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Dysphagia and Longitudinal Changes in Swallowing Function in Adults with Niemann-Pick Disease Type C Treated with Miglustat.
    Lewis C; Keage M; Watanabe M; Schubiger D; Velakoulis D; Walterfang M; Vogel AP
    Dysphagia; 2021 Jun; 36(3):362-373. PubMed ID: 32562141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1.
    Rodriguez-Gil JL; Watkins-Chow DE; Baxter LL; Elliot G; Harper UL; Wincovitch SM; Wedel JC; Incao AA; Huebecker M; Boehm FJ; Garver WS; Porter FD; Broman KW; Platt FM; Pavan WJ
    Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 31996359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered transition metal homeostasis in Niemann-Pick disease, type C1.
    Hung YH; Faux NG; Killilea DW; Yanjanin N; Firnkes S; Volitakis I; Ganio G; Walterfang M; Hastings C; Porter FD; Ory DS; Bush AI
    Metallomics; 2014 Mar; 6(3):542-53. PubMed ID: 24343124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.
    Campbell K; Cawley NX; Luke R; Scott KEJ; Johnson N; Farhat NY; Alexander D; Wassif CA; Li W; Cologna SM; Berry-Kravis E; Do AD; Dale RK; Porter FD
    Biomark Res; 2023 Jan; 11(1):14. PubMed ID: 36721240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182T>C) mutation in the NPC1 gene.
    Li R; Pradhan M; Xu M; Roeder A; Beers J; Zou J; Liu C; Porter FD; Zheng W
    Stem Cell Res; 2020 Apr; 44():101737. PubMed ID: 32114296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
    Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
    Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
    Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease.
    Houben T; Magro Dos Reis I; Oligschlaeger Y; Steinbusch H; Gijbels MJJ; Hendrikx T; Binder CJ; Cassiman D; Westerterp M; Prickaerts J; Shiri-Sverdlov R
    Front Immunol; 2018; 9():3089. PubMed ID: 30666257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1.
    Prabhu AV; Kang I; De Pace R; Wassif CA; Fujiwara H; Kell P; Jiang X; Ory DS; Bonifacino JS; Ward ME; Porter FD
    BMC Biol; 2021 Oct; 19(1):218. PubMed ID: 34592985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR).
    Bolton SC; Soran V; Marfa MP; Imrie J; Gissen P; Jahnova H; Sharma R; Jones S; Santra S; Crushell E; Stampfer M; Coll MJ; Dawson C; Mathieson T; Green J; Dardis A; Bembi B; Patterson MC; Vanier MT; Geberhiwot T
    Orphanet J Rare Dis; 2022 Feb; 17(1):51. PubMed ID: 35164809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for
    Tseng WC; Loeb HE; Pei W; Tsai-Morris CH; Xu L; Cluzeau CV; Wassif CA; Feldman B; Burgess SM; Pavan WJ; Porter FD
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.